Genentech Speaks The Language Of CMOs

Todd Mabe, head of External Quality, Biologics Drug Substance for Genentech, knows his company has an inherent advantage when contracting for biologics production capacity. “It’s fair to say we’re a popular customer target,” he explains. But thatdoesn’t make the selection process a walk in the park.

Source: Pharmaceutical Online News - March 28, 2016 Category: Pharmaceuticals Source Type: news